KCT0006975尚未招募未知
Comparison of postoperative nausea and vomiting between remimazolam and sevoflurane in middle ear surgery
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20?(Year) 至 80?(Year)（—）
- 性别
- All
入选标准
- •American Society of Anesthesiologists physical status classification I, II, or III.
- •- Patients aged 20 to 80 who agreed to participate in the study.
- •- Patients undergoing surgery in Dong-A university hospital.
排除标准
- •- Patients with hypersensitivity to Remimazolam and other benzodiazepines.
- •- Emergency operation.
- •- Patients with morbid obesity. (BMI >35)
- •- Patients in the intensive care unit or previously scheduled to be transferred to the intensive care unit after surgery.
- •- Maternity or lactating club.
- •- Patients who are unable to communicate and have cognitive impairment.
- •- Patients whose bispectral index is not adjusted to between 40 and 60 even after 30 minutes from the start of surgery.
- •- Patient's refusal.
研究者
相似试验
已完成
Unknown
Comparison of postoperative nausea and vomiting between general anesthesia with remimazolam and general anesthesia with propofol: A randomized non-inferiority trial.Patients undergoing surgery under general anesthesia who do not receive postoperative opioids by epidural analgesia nor intravenous PCA.JPRN-UMIN000049707Kobe city medical center general hospital91
尚未招募
不适用
Comparison of Postoperative Nausea and Vomiting between Remimazolam and propofol in Pati ents Undergoing Oral and Maxillofacial SurgeryKCT0006965Pusan National University Dental Hospital200
招募中
不适用
Comparison of postoperative nausea and vomiting with remimazolam and propofolbreast cancerJPRN-UMIN000044442Suwa Red-Cross Hospital60
招募中
Unknown
Postoperative nausea and vomiting prevalence in patients with routine NPO and NPO with clear fluids 2 hours before surgeryausea and vomiting.Nausea and vomitingIRCT20190325043107N36Tabriz University of Medical Sciences80
已完成
不适用
Comparison of postoperative nausea and vomiting accoring to manual and target controlled infusion of remifentanil in gynecological patients undergoing pelviscopic surgery - Randomized controlled trialKCT0007703BCWORLD PHARM90